Table of Contents
Overview
New York, NY – June 18, 2025 – Global Single-use Pump Market size is expected to be worth around US$ 1711.9 Million by 2034 from US$ 478.3 Million in 2024, growing at a CAGR of 13.6% during the forecast period from 2025 to 2034. In 2024, North America led the market, achieving over 43.4% share with a revenue of US$ 207.5 Million.
The single-use pump market is witnessing significant growth, driven by the increasing adoption of disposable systems in biopharmaceutical manufacturing. These pumps are designed for one-time use, eliminating the need for cleaning and sterilization between batches, which enhances operational efficiency and reduces contamination risks.
Single-use pumps are especially critical in the production of biologics, vaccines, and cell and gene therapies, where sterile conditions are essential. Their integration into upstream and downstream processes supports flexible manufacturing, shortens turnaround times, and enables cost-effective small-batch production. According to the U.S. Food and Drug Administration (FDA), the growing trend toward personalized medicine and rapid bioprocessing solutions is accelerating the shift to disposable technologies.
Key advantages of single-use pumps include easy scalability, reduced cross-contamination, and compatibility with automation systems. As facilities expand to meet global biologics demand, the use of such systems is expected to rise, particularly in North America and Europe, where regulatory compliance and advanced infrastructure support their deployment.
Government agencies and health organizations continue to promote cleanroom manufacturing practices, making single-use pumps a critical component of modern pharmaceutical and bioprocessing environments. With continuous innovation in pump materials and design, the market is expected to play a vital role in the next generation of therapeutic production.
Key Takeaways
- Market Size: The global single-use pump market is projected to reach approximately US$ 1,711.9 million by 2034, up from US$ 478.3 million in 2024.
- Market Growth: This growth reflects a robust compound annual growth rate (CAGR) of 13.6% during the forecast period 2025 to 2034.
- Product Analysis: Among the various product types, peristaltic pumps dominate the market, contributing to approximately 38.5% of the total revenue share.
- Material Analysis: Polypropylene is the leading material used in single-use pumps, accounting for approximately 64.2% of the overall market revenue.
- End-Use Analysis: The pharmaceutical and biopharmaceutical sector represents the largest end-use segment, comprising around 31.9% of total market demand.
- Regional Analysis: In 2024, North America held the leading position in the global market, capturing more than 43.4% market share, equivalent to US$ 207.5 million in revenue.
Segmentation Analysis
- Product Type Analysis: The single-use pump market is categorized into Peristaltic, Diaphragm, Gear, Piston Pumps, Accessories, and Others. Peristaltic pumps lead with 38.5% revenue share, driven by their effectiveness in sterile biopharmaceutical applications. Diaphragm pumps follow, suited for viscous fluids in biotech settings. Gear and piston pumps offer precise flow for dosing and cell therapy. Accessories like tubing and connectors support system integration, while niche pumps (centrifugal, screw) serve specialized research and industrial applications.
- Material Analysis: By material, the market includes Polypropylene (PP), Polyethylene (PE), and Others. Polypropylene dominates with 64.2% revenue share due to its strong chemical resistance, heat stability, and sterilization compatibility, making it ideal for biopharma applications. Polyethylene follows as a durable and non-reactive alternative, used in fluid transfer with lower mechanical requirements. Other materials such as PVC and EVA serve specific roles in niche use cases but maintain a minor overall market share.
- End-User Analysis: The market is segmented by end user into Pharmaceutical & Biopharmaceutical, Food & Beverages, Chemicals, Water & Wastewater, Cosmetics & Personal Care, and Others. The pharmaceutical and biopharmaceutical segment leads with 31.9% share due to high demand for contamination-free fluid handling in drug and vaccine production. Other segments utilize these pumps for hygienic processing (F&B), chemical dosing, water treatment, and precise ingredient transfer in personal care and diagnostic labs.
Market Segments
By Product Type
- Peristaltic Pumps
- Diaphragm Pumps
- Gear Pumps
- Piston Pumps
- Accessories
- Other (Centrifugal, Screw, etc.)
By Material
- Polypropylene (PP)
- Polyethylene (PE)
- Others
By End User Industry
- Pharmaceutical & Biopharmaceutical
- Food & Beverages
- Chemicals
- Water & Wastewater
- Cosmetics & Personal Care
- Other (Healthcare, Diagnostics, etc.)
Regional Analysis
In 2024, North America secured a dominant position in the global single-use pump market, accounting for over 43.4% of total market share, equivalent to US$ 207.5 million in value. This leadership is largely attributed to the region’s advanced biopharmaceutical manufacturing infrastructure and rising investments in biologics, cell therapies, and personalized medicine. These developments have significantly increased the demand for sterile, single-use fluid handling systems across upstream and downstream processing.
The widespread presence of leading pharmaceutical and biotechnology companies in the United States and Canada has further accelerated market growth. These organizations have integrated single-use pumps to improve process efficiency, minimize cross-contamination, and comply with stringent regulatory standards, especially in FDA-regulated environments. The growing number of clinical trials and commercial drug production facilities in the region has also strengthened market demand.
Government support for pharmaceutical research and development, combined with a robust healthcare ecosystem, continues to promote the adoption of flexible, scalable, and disposable technologies. Additionally, heightened focus on pandemic preparedness and rapid response capabilities has driven a shift toward modular manufacturing platforms, reinforcing North America’s role as a critical hub for global single-use pump market expansion.
Emerging Trends
- Expansion into Continuous Bioprocessing: Single-use pumps are increasingly integrated throughout continuous bioprocessing trains, supplying everything from initial inoculum transfer to downstream operations. This trend reflects a shift from hybrid systems toward fully disposable process lines, offering greater flexibility and reducing changeover times between batches.
- Regulatory Endorsement to Reduce Contamination Risk: FDA’s current Good Manufacturing Practice guidance explicitly recognizes the use of presterilized, single-use disposable equipment such as pumps to minimize cleaning validation and contamination hazards in sterile drug production. Outsourcing facilities may rely on supplier certificates of analysis in lieu of in-house sterility testing for these components.
- Standardization of Extractables and Leachables: Industry and regulators are collaborating to harmonize testing standards for materials used in single-use pumps. The Bioprocess Systems Alliance, alongside agencies including NIH and the U.S. Pharmacopeia, is developing guidelines to assess extractables (substances leached during aggressive testing) and leachables (substances migrating into the drug product).
- Lifecycle Design and Sustainability Focus: Engineering best-practice guides are emphasizing the entire lifecycle of single-use components, from gamma-irradiation resistance through end-of-life waste management. This reflects growing demand for circular-economy approaches, ensuring pumps maintain integrity during transport, use, and disposal while meeting environmental sustainability goals.
Use Cases
- Media Transfer and Aseptic Sampling: In upstream bioprocessing, single-use peristaltic pumps facilitate cell-culture media transfer, buffer preparation, and closed aseptic sampling. An NCBI study notes that virtually every operation in continuous and batch processes from tubing connections to sample withdrawal is now supported by disposable pump solutions, enhancing sterility and reducing cross contamination.
- Sterile Fluid Handling in Vaccine Production: Single-use pumps are critical in closed-loop systems for vaccine manufacture, where they handle high-volume, sterile fluid transfers. Compared to traditional stainless-steel setups, disposable systems can deliver cost savings of over 60% by eliminating cleaning and sterilization cycles, as seen in single-use bioreactor implementations.
- Rapid Facility Changeover in Contract Manufacturing: Contract development and manufacturing organizations (CDMOs) leverage single-use pumps to switch production lines rapidly. By accepting supplier-provided sterility certificates for pump assemblies, these facilities reduce cleaning-validation requirements and accelerate batch turnarounds, supporting higher throughput in small-batch and personalized-medicine workflows.
- Cryopreservation of Biologic Working Stocks: Flexible single-use pump assemblies are used to automate filling of cryogenic storage bags with cell banks and viral vectors. This application supports large working-stock aliquots, maintaining aseptic integrity during freeze-thaw cycles and enabling scalable biobanking operations.
Conclusion
The global single-use pump market is poised for sustained growth, driven by rising biopharmaceutical production needs, technological advancements, and increasing regulatory support for disposable systems. With strong adoption across vaccine manufacturing, biologics, and personalized therapies, these pumps enhance sterility, reduce contamination risk, and streamline operations.
North America leads due to its robust infrastructure and innovation in life sciences. As sustainability, continuous processing, and regulatory standardization evolve, single-use pump technologies will remain integral to next-generation bioprocessing solutions, enabling flexible, efficient, and compliant manufacturing practices across a broad range of critical healthcare and industrial applications.
Discuss your needs with our analyst
Please share your requirements with more details so our analyst can check if they can solve your problem(s)
